Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)

Market Cap	1.24B
Revenue (ttm)	260.46M
Net Income (ttm)	-29.68M
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	0.00 (2.22%)
Ex-Dividend Date	Sep 27, 2024

Volume	200
Average Volume	n/a
Open	0.1218
Previous Close	0.1000
Day's Range	0.1000 - 0.1218
52-Week Range	0.0492 - 0.1218
Beta	0.58
RSI	51.22
Earnings Date	Aug 29, 2025

About SHPHF

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,667
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHPHF

Financial Performance

In 2024, SHPHF's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY